Journal
AMERICAN JOURNAL OF CARDIOLOGY
Volume 93, Issue 12, Pages 1533-1535Publisher
EXCERPTA MEDICA INC
DOI: 10.1016/j.amjcard.2004.03.009
Keywords
-
Categories
Ask authors/readers for more resources
The purpose of this trial was to assess whether the addition of hyperbaric oxygen to percutaneous coronary intervention can reduce clinical restenosis. Major adverse cardiac events at 6 months were found in only 1 of 24 patients (4%) who received hyperbaric oxygen compared with 13 of 37 patients (35%) who did not. (C) 2004 by Excerpta Medica, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available